Fecal test guided care vs usual care for ulcerative colitis
Part of Digestive system clinical trials.
This study tests whether using a simple stool test to guide treatment is better than usual care for people with ulcerative colitis in remission. It aims to keep you in remission longer and prevent flare-ups.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have had ulcerative colitis for at least 6 months.
- Your UC is currently in remission (mild or no symptoms) and confirmed by a colonoscopy in the last 12 weeks.
- You have been on the same maintenance medications for at least 8 weeks.
- You are not using steroids (like prednisone) now or in the last 8 weeks.
- You are not pregnant, breastfeeding, or taking part in another trial.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at whether early stool tests (fecal immunochemical test and calprotectin) can predict when ulcerative colitis symptoms might return. It is for people who have never taken biologic medications.
This study looks at whether stool tests, combined with a special camera test of the colon, can help find early signs of colon changes in people who have had ulcerative colitis for a long time. It aims to improve how we monitor for any serious changes like cancer.
This study looks at whether a simple stool test can tell if treatment is healing the gut lining in people with moderate to severe ulcerative colitis who are starting their first biologic medicine. If it works, this test might help doctors adjust treatment earlier.
This study looks at stool samples to see if certain markers can quickly tell whether a biologic medicine is starting to work for moderate-to-severe ulcerative colitis. If successful, this could help doctors make faster, smarter treatment decisions.
This study tests whether a combination of fecal transplant (transferring healthy stool into your gut) and dietary changes can help control inflammation in people recently diagnosed with active ulcerative colitis. It may offer a new treatment option before starting stronger medications.
This trial tests whether adding a probiotic supplement and trace elements to your current treatment helps manage mild to moderate ulcerative colitis. It aims to see if these additions can improve symptoms and quality of life.
Hear when a new Noninvasive Biomarkers trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.